The long‐term clinical course of patients with cutaneous melanoma

The clinical course of cutaneous melanoma is associated with pathologic and clinical factors, such as thickness, ulceration, and location of tumor and gender of the patient. The authors used a parametric survival model that incorporated a cured fraction of patients to translate these factors into specific estimates of long‐term outcome.

[1]  Martin F. Mihm,et al.  A new American Joint Committee on Cancer staging system for cutaneous melanoma , 2000, Cancer.

[2]  Eric J. Feuer,et al.  Parametric cure models of relative and cause-specific survival for grouped survival times , 2000, Comput. Methods Programs Biomed..

[3]  J. Gamel,et al.  Comparison of parametric and non-parametric survival methods using simulated clinical data. , 1997, Statistics in medicine.

[4]  A. Sober,et al.  Ultra‐late recurrence (15 years or longer) of cutaneous melanoma , 1997, Cancer.

[5]  C. Garbe,et al.  Primary cutaneous melanoma. Prognostic classification of anatomic location , 1995, Cancer.

[6]  S. George,et al.  Skin melanoma. Cured fraction and survival time as functions of thickness, site, histologic type, age, and sex , 1993, Cancer.

[7]  H. Seigler,et al.  Late Recurrence of Malignant Melanoma: Analysis of 168 Patients , 1990, Annals of surgery.

[8]  A. Halpern,et al.  Model predicting survival in stage I melanoma based on tumor progression. , 1989, Journal of the National Cancer Institute.

[9]  C. Karakousis,et al.  Tumor thickness and prognosis in clinical stage I malignant melanoma , 1989, Cancer.

[10]  F. Meyskens,et al.  Cutaneous malignant melanoma (arizona cancer center experience). I. Natural history and prognostic factors influencing survival in patients with stage i disease , 1988, Cancer.

[11]  L. Rutqvist,et al.  Is breast cancer a curable disease? A study of 14,731 women with breast cancer from the cancer registry of Norway , 1984, Cancer.

[12]  M. Palmer,et al.  Distribution of survival times of 12,000 head and neck cancer patients who died with their disease. , 1976, British Journal of Cancer.

[13]  J. Boag,et al.  A test of several parametic statistical models for estimating success rate in the treatment of carcinoma cervix uteri. , 1975, British Journal of Cancer.

[14]  J. Boag,et al.  Maximum Likelihood Estimates of the Proportion of Patients Cured by Cancer Therapy , 1949 .